GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » Forward PE Ratio

Straumann Holding AG (FRA:QS51) Forward PE Ratio : 43.67 (As of Apr. 29, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Straumann Holding AG Forward PE Ratio?

Straumann Holding AG's Forward PE Ratio for today is 43.67.

Straumann Holding AG's PE Ratio without NRI for today is 50.04.

Straumann Holding AG's PE Ratio for today is 89.68.


Straumann Holding AG Forward PE Ratio Historical Data

The historical data trend for Straumann Holding AG's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG Forward PE Ratio Chart

Straumann Holding AG Annual Data
Trend 2015-12 2016-12 2017-12 2018-12 2019-09
Forward PE Ratio
27.62 28.65 37.45 27.78 33.33

Straumann Holding AG Semi-Annual Data
2015-12 2016-03 2016-06 2016-09 2016-12 2017-03 2017-06 2017-09 2017-12 2018-03 2018-06 2018-09 2018-12 2019-03
Forward PE Ratio 27.62 28.74 28.49 27.47 28.65 33.11 37.17 31.95 37.45 33.11 40.82 34.01 27.78 36.10

Competitive Comparison of Straumann Holding AG's Forward PE Ratio

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Straumann Holding AG's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's Forward PE Ratio falls into.



Straumann Holding AG Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Straumann Holding AG  (FRA:QS51) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Straumann Holding AG Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Straumann Holding AG (FRA:QS51) Business Description

Address
Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (FRA:QS51) Headlines

No Headlines